vaccines and immunoinformatics approaches
vaccines and immunoinformatics approaches is a research topic within Molecular Biology. Science Explorer counts 21k research works in it since 1950. 21.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the prediction of peptide-major histocompatibility complex (MHC) binding affinity, epitope prediction, and immunoinformatics for vaccine design. It covers topics such as antigen presentation, HLA class I and II molecules, bioinformatics tools for epitope prediction, T-cell and B-cell epitopes, and proteasomal cleavage.
- Peptide-MHC Binding
- Epitope Prediction
- Immunoinformatics
- Vaccine Design
- Antigen Presentation
- HLA Class I and II
- Bioinformatics Tools
- T-Cell Epitopes
- B-Cell Epitopes
- Proteasomal Cleavage
- Research works
- 21k fractional, since 1950
- In the world top 10%
- 4.4k per year above
- Top-10% rate
- 21.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +75% the tick is no change
Which countries lead vaccines and immunoinformatics approaches research?
By volume, the United States and China publish the most (1.1k and 954 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.1k works
- 2 China 954 works
- 3 India 491 works
- 4 Iran 216 works
- 5 United Kingdom 207 works
- 6 Germany 186 works
- 7 Indonesia 152 works
- 8 Brazil 125 works
- 9 Italy 123 works
- 10 France 116 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead vaccines and immunoinformatics approaches research?
By volume in 2022–2025, University of Oxford publishes the most vaccines and immunoinformatics approaches research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and University of North Carolina at Chapel Hill.
By volume, 2022–2025
- 1 University of OxfordUnited Kingdom 22 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
- 3 University of North Carolina at Chapel HillUnited States 17 works
- 4 Vellore Institute of Technology UniversityIndia 17 works
- 5 Harvard UniversityUnited States 16 works
- 6 University of California San DiegoUnited States 16 works
- 7 Shanghai Jiao Tong UniversityChina 16 works
- 8 National Institutes of HealthUnited States 16 works
- 9 National Institute of Allergy and Infectious DiseasesUnited States 15 works
- 10 King Saud UniversitySaudi Arabia 15 works
Who are the leading researchers in vaccines and immunoinformatics approaches?
The most-cited researchers publishing on vaccines and immunoinformatics approaches include Dirk Schadendorf and Matthew Meyerson.
- 1 Dirk Schadendorf Germany 4.4k citations
- 2 Matthew Meyerson United States 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is vaccines and immunoinformatics approaches research done?
The largest centres of vaccines and immunoinformatics approaches research in 2022–2025 are Beijing (China), Tehran (Iran), Shanghai (China) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 47.9 works7.2×
Location quotient: how much more of its research is in vaccines and immunoinformatics approaches than the world average.
Where is the best place to study vaccines and immunoinformatics approaches?
Among universities, judged by research, Indraprastha Institute of Information Technology Delhi, University of Oxford and Shiraz University of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Indraprastha Institute of Information Technology DelhiIndia | 64.3 | 41.4% | 38.5× | 9 | — |
| 2 | University of OxfordUnited Kingdom | 59.9 | 28.8% | 3.2× | 22 | +57.7% |
| 3 | Shiraz University of Medical SciencesIran | 56.4 | 14.5% | 8.6× | 12 | +816.5% |
| 4 | Icahn School of Medicine at Mount SinaiUnited States | 55.9 | 33.5% | 4.0× | 10 | +303.6% |
| 5 | Vellore Institute of Technology UniversityIndia | 52.6 | 26.4% | 3.1× | 17 | +147.9% |
| 6 | King Saud UniversitySaudi Arabia | 52.4 | 26.1% | 3.1× | 15 | — |
| 7 | University of California San DiegoUnited States | 51.0 | 31.0% | 3.5× | 16 | +26.0% |
| 8 | Johns Hopkins UniversityUnited States | 50.8 | 39.3% | 2.5× | 14 | -3.1% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 49.1 | 26.4% | 3.8× | 20 | -8.0% |
| 10 | Harvard UniversityUnited States | 48.7 | 31.5% | 2.4× | 16 | -17.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is vaccines and immunoinformatics approaches research growing?
Output in 2018–2022 was 75% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are vaccines and immunoinformatics approaches.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.